Characteristic (n = 57) | n (%) |
Sex | |
Male | 42 (73.6%) |
Female | 15 (26.4%) |
Median age (y) | 10 (range, 4–18) |
Stage | |
Early stage (IA, IB, and IIA) | 26 (45.6%) |
Advanced stage (IIB–IV) | 31 (54.4%) |
Bulky disease | 23 (40.3%) |
Median follow-up (mo) | 81.6 (range, 11–97.5) |
Subtype | |
Mixed cellularity | 32 (56.1%) |
Nodular sclerosis | 16 (28.1%) |
Lymphocyte rich | 3 (5.2%) |
Lymphocyte depleted | 1 (1.7%) |
NLPHL | 1 (1.7%) |
Unspecified | 4 (7.2%) |
Involved-field radiotherapy | 37 (64.9) |
NLPHL = nodular lymphocyte predominant Hodgkin lymphoma.